If pain persists after nonpharmacologic therapy for osteoarthritis, which is the typical initial pharmacologic option?

Prepare for the Clinical Decision-Making (CDM) Cases Part I test. Equip yourself with valuable questions and insights. Ensure success with clear explanations and strategic study tips!

Multiple Choice

If pain persists after nonpharmacologic therapy for osteoarthritis, which is the typical initial pharmacologic option?

Explanation:
Acetaminophen is the typical initial pharmacologic option after nonpharmacologic therapy for osteoarthritis because it offers analgesia with the best balance of safety for many patients. It provides reliable pain relief for mild to moderate OA and has far fewer gastrointestinal, cardiovascular, or renal risks than NSAIDs, making it a safer first choice for a broad population, including older adults. The main caveat is liver safety—careful dosing is essential and alcohol use should be avoided; it’s not effective as an anti-inflammatory, so if pain persists, NSAIDs may be added or used instead. Duloxetine and opioids are generally considered after NSAIDs or in scenarios where NSAIDs are not suitable, with opioids reserved for refractory pain due to dependence and safety concerns.

Acetaminophen is the typical initial pharmacologic option after nonpharmacologic therapy for osteoarthritis because it offers analgesia with the best balance of safety for many patients. It provides reliable pain relief for mild to moderate OA and has far fewer gastrointestinal, cardiovascular, or renal risks than NSAIDs, making it a safer first choice for a broad population, including older adults. The main caveat is liver safety—careful dosing is essential and alcohol use should be avoided; it’s not effective as an anti-inflammatory, so if pain persists, NSAIDs may be added or used instead. Duloxetine and opioids are generally considered after NSAIDs or in scenarios where NSAIDs are not suitable, with opioids reserved for refractory pain due to dependence and safety concerns.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy